Cedric Francois - May 16, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Cedric Francois
Stock symbol
APLS
Transactions as of
May 16, 2023
Transactions value $
-$2,436,400
Form type
4
Date filed
5/18/2023, 05:10 PM
Previous filing
Apr 28, 2023
Next filing
May 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $80.1K +30K +10.92% $2.67* 305K May 16, 2023 Direct F5
transaction APLS Common Stock Sale -$77.7K -934 -0.31% $83.17 304K May 16, 2023 Direct F5, F6
transaction APLS Common Stock Sale -$151K -1.8K -0.59% $83.85 302K May 16, 2023 Direct F5, F7
transaction APLS Common Stock Sale -$1.24M -14.6K -4.84% $85.01 287K May 16, 2023 Direct F5, F8
transaction APLS Common Stock Sale -$258K -3.01K -1.05% $85.90 284K May 16, 2023 Direct F5, F9
transaction APLS Common Stock Sale -$655K -7.53K -2.65% $87.02 277K May 16, 2023 Direct F5, F10
transaction APLS Common Stock Sale -$186K -2.12K -0.77% $87.67 275K May 16, 2023 Direct F5, F11
transaction APLS Common Stock Options Exercise $53.4K +20K +7.28% $2.67* 295K May 17, 2023 Direct F12
holding APLS Common Stock 383K May 16, 2023 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2) F1
holding APLS Common Stock 634K May 16, 2023 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023) F2
holding APLS Common Stock 300K May 16, 2023 Indirect Owner (The Francois Grossi Trust) F3
holding APLS Common Stock 234K May 16, 2023 Indirect Owner (The Francois-DuBois Educational Trust) F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -30K -8.57% $0.00 320K May 16, 2023 Common Stock 30K $2.67 Direct F5, F13
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -20K -6.25% $0.00 300K May 17, 2023 Common Stock 20K $2.67 Direct F12, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
F2 The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F3 The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F4 The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
F5 This is a scheduled exercise & sale from 10b5-1 trading plan.
F6 This transaction was executed in multiple trades at prices ranging from $82.500 - $83.490. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $83.500 - $84.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8 This transaction was executed in multiple trades at prices ranging from $ $84.545 - $85.520. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9 This transaction was executed in multiple trades at prices ranging from $85.550 - $86.540. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10 This transaction was executed in multiple trades at prices ranging from $86.550 - $87.490. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F11 This transaction was executed in multiple trades at prices ranging from $87.570 - $87.795. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F12 This is a scheduled exercise from 10B5-1 trading plan.
F13 This option was granted on December 5, 2013 and fully vested.